Inspire Veterinary Partners, Inc. Class A (IVP) AI Stock Analysis

• Market Cap: $9.10M
• Dividend Yield: N/A
• Average Volume (3M): 78.32K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.99
• Revenue Growth: -10.59%
• EPS Growth: 99.33%
• Country: US
• Employees: 113
• Sector: Consumer Cyclical
• Sector Strength: 58
• Industry: Personal Products & Services
• EPS (TTM): -0.43
• Shares Outstanding: 2,119,551
• 10 Day Avg. Volume: 86,888
• 30 Day Avg. Volume: 78,323
• PEG Ratio: -0.65
• Price to Book (P/B): -166.97
• Price to Sales (P/S): 0.00
• P/FCF Ratio: -302.45
• Enterprise Value/Market Cap: 96.79
• Enterprise Value/Revenue: 13.31
• Enterprise Value/Gross Profit: 303.59
• Enterprise Value/Ebitda: -21.34
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 49 Neutral
• Price Target: $2.00 ▲(12.99%Upside)

The overall stock score is impacted significantly by the company's financial struggles, with high leverage and negative cash flow posing substantial risks. Positive market momentum provides some short-term optimism, complemented by strategic acquisitions and financing activities aimed at growth. However, the negative valuation metrics due to ongoing losses remain a concern.

Inspire Veterinary Partners, Inc. Class A Business Overview & Revenue Model

Company Description

Inspire Veterinary Partners, Inc. owns and operates veterinary hospitals in the United States. The company specializes in small animal general practice hospitals, which serve companion pets, canine, and feline breeds. Its hospitals provide preventive care for companion animals consisting of annual health exams and parasite control; dental health; nutrition and body condition counseling; neurological examinations; radiology; bloodwork; and skin and coat health, and other breed specific preventive care services. The company also provides surgical services, which include soft tissue procedures, such as spays and neuters, mass removals, splenectomies, gastropexies, orthopedic procedures, and other surgical offerings; and care and alternative procedures, such as acupuncture, chiropractic, and other health and wellness services. Inspire Veterinary Partners, Inc. was incorporated in 2020 and is based in Virginia Beach, Virginia.

How the Company Makes Money

Inspire Veterinary Partners, Inc. generates revenue through its network of veterinary clinics by offering a range of services to pet owners and livestock farmers. The company's primary revenue streams include fees for medical consultations, diagnostic tests, surgical procedures, and sales of veterinary products such as medications and pet food. Additionally, IVP may engage in partnerships with suppliers of veterinary products and pharmaceuticals, which can provide additional revenue through product sales and distribution agreements. Revenue is also supported by wellness plans and membership programs that encourage regular visits and preventive care, fostering customer loyalty and recurring income.

Inspire Veterinary Partners, Inc. Class A Financial Statement Overview

Summary

Inspire Veterinary Partners, Inc. is facing significant financial challenges with consistent net losses, high leverage, and negative free cash flow. These factors indicate potential risks in terms of liquidity and financial stability, requiring strategic actions to improve profitability and cash flow management.

Income Statement

Inspire Veterinary Partners, Inc. has seen fluctuating revenues with a recent decline in total revenue during TTM. Gross profit margins have been weak, and the company continues to operate at a net loss, indicating challenges in achieving profitability. The negative EBIT and EBITDA margins further highlight ongoing operational inefficiencies and cost management issues.

Balance Sheet

The company has a high debt-to-equity ratio, reflecting significant leverage which poses financial risk. Stockholders’ equity remains low, resulting in a low equity ratio. Negative equity in previous years indicates potential financial instability, although there has been some improvement as of the latest TTM data.

Cash Flow

Inspire Veterinary Partners, Inc. has experienced negative free cash flow, indicating challenges in generating sufficient cash from operations to cover capital expenditures. The operating cash flow to net income ratio is unfavorable due to consistent net losses, reflecting ongoing cash flow struggles.

Breakdown
TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement		Total Revenue
15.40M	16.59M	16.68M	9.83M	2.55M	0.00
	Gross Profit
2.90M	6.86M	3.55M	2.55M	829.29K	0.00
	EBIT
-8.90M	-9.03M	-7.19M	-3.52M	-1.05M	-5.52K
	EBITDA
-8.69M	-9.50M	-10.84M	-2.91M	-977.46K	0.00
	Net Income Common Stockholders
-13.26M	-14.26M	-14.79M	-4.91M	-1.33M	-5.52K
Balance Sheet		Cash, Cash Equivalents and Short-Term Investments
1.74M	523.69K	178.96K	444.25K	2.06M	21.97K
	Total Assets
20.66M	20.20M	21.79M	20.19M	6.33M	21.97K
	Total Debt
15.24M	16.37M	18.42M	23.61M	6.69M	0.00
	Net Debt
13.51M	15.85M	18.24M	23.17M	4.64M	-21.97K
	Total Liabilities
17.66M	18.63M	22.58M	25.32M	7.20M	0.00
	Stockholders Equity
3.00M	1.56M	-788.26K	-5.14M	-869.09K	21.97K
Cash Flow		Free Cash Flow
-8.31M	-10.24M	-4.20M	-2.84M	-2.32M	-5.52K
	Operating Cash Flow
-8.21M	-10.01M	-3.82M	-2.66M	-1.01M	-5.52K
	Investing Cash Flow
-101.31K	-238.00K	-1.87M	-14.67M	-4.02M	0.00
	Financing Cash Flow
9.90M	10.59M	5.63M	15.71M	7.07M	269.16K

Inspire Veterinary Partners, Inc. Class A Technical Analysis

• Technical Analysis Sentiment: Neutral
• Last Price: 1.77
• 50DMA: Positive
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IVP, the sentiment is Neutral. The current price of 1.77 is above the 20-day moving average (MA) of 1.66, above the 50-day MA of 1.57, and below the 200-day MA of 6.02, indicating a neutral trend. The MACD of 0.07 indicates Negative momentum. The RSI at 54.78 is Neutral, neither overbought nor oversold. The STOCH value of 65.29 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for IVP.

Inspire Veterinary Partners, Inc. Class A Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
JXG	63 Neutral	$9.90M	1.15	17.05%	―	56.53%	10.88%
Sector *	62 Neutral	$6.82B	11.05	2.80%	4.32%	2.67%	-24.92%
IVP	49 Neutral	$9.10M	―	-809.91%	―	-10.59%	99.33%
JWEL	46 Neutral	$4.22M	―	-37.82%	―	-16.85%	-9.20%
VMAR	44 Neutral	$8.76M	―	-80.86%	―	-55.43%	55.17%
CTNT	44 Neutral	$4.31M	―	-28.60%	―	―	―
VEEE	42 Neutral	$4.97M	―	-54.97%	―	-57.48%	-27.43%

Inspire Veterinary Partners, Inc. Class A Corporate Events

Inspire Veterinary Partners Acquires Debary Animal Clinic

On June 5, 2025, Inspire Veterinary Partners, Inc. completed the acquisition of Debary Animal Clinic and its related real estate assets in Florida, marking its fifth acquisition in the state. This acquisition is expected to add approximately $1.8 million in annual revenue and increase the company’s network of animal hospitals to 14, enhancing its presence in the Florida pet care market.

Inspire Veterinary Partners Issues Discount Notes for Capital

On May 30, 2025, Inspire Veterinary Partners, Inc. issued Original Issue Discount Notes to 1800 Diagonal Lending LLC and Boot Capital LLC, with principal amounts of $204,700 and $92,000 respectively, to be used for general working capital. These notes, which mature on March 30, 2026, include provisions for interest payments and allow the lenders to convert the debt into shares of the company’s common stock under certain conditions, impacting the company’s financial strategy and stakeholder interests.

Inspire Veterinary Partners Secures CEO Employment Agreement

Inspire Veterinary Partners, Inc. has formalized an employment agreement with its current CEO, Kimball Carr, for an initial two-year term. The agreement outlines Mr. Carr’s responsibilities, compensation, and conditions for termination, aiming to ensure his full commitment to the company’s interests. The contract includes a base salary, performance bonuses, potential stock awards, and non-disclosure provisions, while also detailing circumstances under which either party may terminate the agreement.

Inspire Veterinary Partners Announces Securities Purchase Agreement

On March 25, 2025, Inspire Veterinary Partners announced a securities purchase agreement with an institutional investor to issue and sell shares of Class A Common Stock and warrants in a registered direct offering expected to close on March 26, 2025. This offering, priced at $1.83 per share, aims to raise approximately $2.0 million initially, with the potential for an additional $4.0 million upon full exercise of the warrants. The company has engaged D. Boral Capital LLC as the placement agent and is required to seek stockholder approval for the issuance of shares upon warrant exercise within 75 days. The move is part of Inspire’s strategy to expand its operations and acquire more veterinary hospitals, enhancing its market positioning in the pet healthcare industry.